ABPWW

Other

Abpro Holdings Inc - Warrants (12/11/2029)

—PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving ABPWW Today?

No stock-specific AI insight has been generated for ABPWW yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap—

P/E Ratio—

EPS—

Dividend Yield—

Dividend / Share—

ROE—

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding—

ABPWW News

3 articles

Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell EngagerYahoo Finance·Nov 4, 2025
Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025Yahoo Finance·Nov 3, 2025
BC-Most Active StocksYahoo Finance·Aug 5, 2025

All 3 articles loaded

Price Data

Open—

Previous Close—

Day High—

Day Low—

52 Week High$0.07

52 Week Low$0.00

Fundamentals

Market Cap—

P/E Ratio—

EPS—

Dividend Yield—

Dividend / Share—

ROE—

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding—

About Abpro Holdings Inc - Warrants (12/11/2029)

Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. The company is headquartered in Woburn, Massachusetts.

abpro.co

Listed March 7, 2022

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SIC—

CIK—

Composite FIGI—

Share Class FIGI—